Unravel Biosciences Submits Clinical Study Applications for Rett and Pitt Hopkins Syndromes
Unravel Biosciences has submitted clinical study applications for RVL-001 trials targeting Rett and Pitt Hopkins syndromes to Colombia's INVIMA for priority review.